BioSpace News Archive

Crinetics Pharmaceuticals, Inc. will provide a company update at the 40th annual J.P. Morgan Healthcare Conference today, Wednesday, January 12th at 4:30 PM Eastern Time / 1:30 PM Pacific Time.

Quipt Home Medical Corp. is regrettably announcing the passing of Eugene Ewing, Independent Board Member and Chair of the Audit Committee.

NEXGEL, Inc. today announced the launch of its MEDAGEL ClearComfort Hydrogel Patch.

Nirogy Therapeutics today announced that it has appointed life science veteran Simon Pedder, Ph.D., as Chief Executive Officer (CEO) and to the Company’s Board of Directors.

BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), today announced key research data published in two leading peer-reviewed industry journals highlighting the durability and cost-effectiveness of its proprietary Deep TMS™ treatment for patients coping with obsessive-compulsive disorder (OCD).

It is with profound sadness that Hepion Pharmaceuticals, Inc. announces the passing of Thomas Adams, Ph.D., a member of its Board of Directors.

PDS Biotechnology Corporation announced that the initial safety data from its VERSATILE-002 study has been accepted for presentation at the 2022 Multidisciplinary Head and Neck Cancers Symposium being held February 24-26, 2022, at the JW Marriott Phoenix Desert Ridge Resort and Spa, Phoenix, AZ.

Heat Biologics, Inc. today announced promising new preclinical data regarding PTX-35 has been accepted for publication in the American Journal of Transplantation.

Gracell Biotechnologies Inc. announced that its newly established research facility, the Innovation Center, is scheduled to open in San Diego, California, during the first quarter of 2022.

I-Mab today announced that the first patient had been dosed in its China phase 2 study (NCT05145907) of efineptakin alfa.